株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ウィルス学市場予測:種類、用途、エンドユーザー、地域別

Virology Market: By Type ; By Application ; By End-User & By Region - 2019-2023

発行 IndustryARC 商品コード 422720
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
ウィルス学市場予測:種類、用途、エンドユーザー、地域別 Virology Market: By Type ; By Application ; By End-User & By Region - 2019-2023
出版日: 2018年12月15日 ページ情報: 英文
概要

当レポートでは、ウィルス学市場について調査し、市場の促進・抑制要因や市場の機会、種類、用途、エンドユーザー、地域別の市場動向を分析・予測し、市場のエントロピーや主要企業のプロファイルなどをまとめています。

第1章 ウィルス学市場の概要

第2章 エグゼクティブサマリー

第3章 ウイルス学市場の情勢

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • ファイブフォース分析

第5章 戦略分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品および市場のライフサイクル分析
  • 供給元・販売元

第6章 ウイルス学市場:種類別

  • 診断テスト
  • ウイルス性感染管理
  • 抗ウイルス化学療法
  • ウイルス抑制因子

第7章 ウィルス学市場:用途別

  • 皮膚・軟部組織感染症
  • 気道感染症
  • 消化器官感染症
  • 尿路感染症
  • 眼感染症
  • 中枢神経感染症
  • 性感染症
  • 周産期感染症

第8章 ウィルス学市場:エンドユーザー別

  • 病院
  • 診療所
  • 臨床研究施設
  • 診断センター
  • 血液バンク
  • 薬局

第9章 ウィルス学市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域(RoW)
    • ブラジル
    • その他

第10章 ウィルス学市場:エントロピー

  • 市場の拡大
  • 技術の進歩
  • 合併・買収・合弁事業
  • 供給・契約

第11章 企業プロファイル

第12章 付録

目次

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the leading market holder driven by world class healthcare substructure with technological advancement practice. Asia-Pacific is likely attaining highest growth due to growing healthcare tourism in the nations of China and India. Hospitals and the Laboratories are the most dominating end-use segments

What is virology?

Virology is the scientific discipline concerned with the study of the microbiological or pathological science which involves the study of viruses and viral diseases, including the distribution, biochemistry, disease producing properties, physiology, molecular biology, ecology, cultivation, evolution, genetics and clinical aspects of viruses. Virology explain about the interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, ways to infect and exploit host cells for reproduction, and their use in research and therapy.

Market Research and Market Trends of virology market

Notable advances in nanotechnology, nanostructure-based electrical sensors have been emerged as promising platforms for real-time, sensitive detection of numerous bioanalytes. Using Nanopore-Based Resistive-Pulse Sensing Techniques, scientists are determining both the dimensions and the number of viruses. So, this provides important complementary information and detect all viruses and virus related particles.

Microbiology testing considered as one of the most rapidly growing segments in the diagnostics industry. The major driving forces for this include continuous spread of HIV, which is the world's major health threat and is a key factor contributing to the rise in opportunistic infections, bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immune suppressive drug.

Awareness programs about various viruses such as Ebola virus, Flu, Zika virus, STD's, AIDS are the key factor increasing people awareness and eventually increasing the market growth by employing the virology applications.

Who are the Major Players in virology market?

The companies referred in the market research report includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Virology Market - Overview

2. Executive Summary

3. Virology Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Virology Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing incidences of global viral epidemics
    • 4.1.2. Growing applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Virology Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Virology Market, By Type

  • 6.1. Diagnosing Test
  • 6.2. Viral Infection Controlling Methods
  • 6.3. Antiviral Chemotherapy
  • 6.4. Interferons

7. Virology Market, By Application

  • 7.1. Skin and Soft Tissue Infections
  • 7.2. Respiratory Tract Infections
  • 7.3. GI Tract Infections
  • 7.4. Urinary Tract Infections
  • 7.5. Eye Infections
  • 7.6. CNS Infections
  • 7.7. Sexually Transmitted Diseases
  • 7.8. Perinatal Infections

8. Virology Market, By End-User

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Laboratories
  • 8.4. Diagnostic Centres
  • 8.5. Blood Banks
  • 8.6. Pharmacies

9. Virology Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Virology Market - Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. GlaxoSmithKline plc
  • 11.2. Abbott Laboratories
  • 11.3. Boehringer Ingelheim Corporation
  • 11.4. Merck and Co. Inc.
  • 11.5. Novartis International AG
  • 11.6. Siemens
  • 11.7. Johnson & Johnson
  • 11.8. AstraZeneca AB
  • 11.9. Roche
  • 11.10. Abivax

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top